(Q37131988)

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

author name string

Michel Marty

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

publication date

7 April 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

published in

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

page(s)

912-920

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18396037

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18396037%20AND%20SRC:MED&resulttype=core&format=json

(Q37131988)

The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)